Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study.
Munaza RiazJingchuan GuoSteven M SmithEric A DietrichDavid E WinchesterHaesuk ParkPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
There was no significant difference in the risk of UTI or genital infection among patients with HFpEF who initiated canagliflozin, dapagliflozin, or empagliflozin.
Keyphrases